BIVI - BioVie awarded up to $13.1M in funding from U.S. DOD for long COVID treatment April, 29 2024 08:23 AM BioVie Inc. 2024-04-29 08:23:10 ET More on BioVie Inc. BioVie stock plunges 43% following public offering pricing BioVie slumps 18%, prices $21M equity offering Seeking Alpha’s Quant Rating on BioVie Inc. Historical earnings data for BioVie Inc. Financial information for BioVie Inc. For further details see: BioVie awarded up to $13.1M in funding from U.S. DOD for long COVID treatment